AUTOLUS
Live / Registered — Registered (as of 09 Jul 2024)
What this means for you
Registered since 09 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79380366
- Registration number
- 7435787
- Mark type
- Stylized text
- Filed
- 05 Sept 2023
- Published for opposition
- 23 Apr 2024
- Registered
- 09 Jul 2024
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 005 — Pharmaceuticals: Medical and veterinary preparations for therapeutic purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; medical preparations for cell therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; medical preparations for gene therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; medical preparations for cancer therapies for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; cells for medical or clinical use, namely, cells featuring chimeric antigen receptors (CAR) and therapeutic preparations thereof for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; antibodies for medical purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors, namely, culture media for cultivating and augmentation of human and animal cells; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes; vaccines
- Class 040 — Treatment of materials: Custom manufacture of therapeutic drugs, namely, cell therapies, cancer therapies and cancer vaccines
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, namely, medical research, scientific research, analysis and testing in the field of human and animal cell, gene and cancer therapies, pharmaceutical product development, research and development of new products; industrial analysis and research services in the field of cell, gene and cancer therapies; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vaccines, including personalised cancer vaccines; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services
- Class 044 — Medical, beauty and agricultural services: Medical services; veterinary services; medical and veterinary services in the nature of extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes, namely, medical services relating to the removal, treatment and processing of human and animal cells; medical and veterinary services in the nature of reinsertion of cells into human and animal patients; providing medical advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies and cancer vaccines
Owner
- Autolus Limited, GB
- Autolus Limited, GB
- Autolus Limited, GB
Prosecution history
- 22 Mar 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 01 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Mar 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 01 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Mar 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 04 Mar 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 10 Jan 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Dec 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Dec 2024 — FINAL DISPOSITION PROCESSED
- 10 Oct 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 09 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 23 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Apr 2024 — PUBLISHED FOR OPPOSITION